Efficacy & Safety of Clindamycin and Tretinoin in Acne
This trial is active, not recruiting.
|Treatment||clindamycin phosphate 1.2% and tretinoin 0.025% gel|
|Sponsor||Callender Center for Clinical Research|
|Collaborator||Society Hill Dermatology|
|Start date||November 2009|
|End date||March 2010|
|Trial size||30 participants|
|Trial identifier||NCT01111994, VDC2009Z|
The purpose of this study is ascertain the efficacy and safety of Clindamycin
Phosphate 1.2% and Tretinoin 0.025% in the treatment of Acne and Post
Inflammatory Hyperpigmentation in patients with skin of color.
|United States||No locations recruiting|
|Other Countries||No locations recruiting|
|Endpoint classification||safety/efficacy study|
|Intervention model||single group assignment|
|Masking||double blind (subject, investigator)|
Improvement of acne and post inflammatory hyperpigmentation
time frame: 3 months
Male or female participants at least 12 years old.
Inclusion Criteria: - Mild to moderate facial acne and mild to moderate post-inflammatory hyperpigmentation - Photo skin types IV - VI - Ages 12 and older - Both sexes - Two week washout period for topical anti-acne medications, medicated cosmetics,and bleaching products - Thirty day washout period for oral corticosteroids, oral antibiotics,and oral contraceptives Exclusion Criteria: - Seborrheic dermatitis - PIH of solely dermal origin - Acne vulfaris known to be resistant to oral antibiotics - Use of erythromycin-containing products - Use of neuromuscular blocking agents - Pregnancy, breastfeeding, a positive pregnancy test in the office, or plans to become pregnant. Women of childbearing age must use reliable forms of contraception (e.g., abstinence, oral contraceptives, or spermicide and condoms).
|Official title||Efficacy & Safety of Clindamycin Phosphase 1.2% and Tretinoin 0.025% Gel vs. Vehicle for the Treatment of Acne and Acne-Induced Post Inflammatory Hyperpigmentation in Patients With Skin of Color|
|Principal investigator||Valerie Callender, MD|
|Description||Acne is a chronic disorder of the pilosebaceous glands characterized by inflammatory papules, pustules, opened and closed comedones, cysts and nodules. Post inflammatory hyperpigmentation is a condition in which an inflammation from a disease such as acne, trauma, or abrasion results in areas of the skin with increased melanin content compared to the surrounding skin. There are several treatments available for acne, which include benzoyl peroxide,antibiotics (topical or oral), and topical retinoids (tretinoin, tazarotene, adapalene). Combination therapy, such as topical retinoid and clindamycin, has been shown to be more effective than monotherapy in addressing all pathogenic factors of acne.|
Call for more information